Abstract-Effects of prizidilol and nipradilol (K-351), (3-adrenoceptor antagonists with vasodilator action, on blood pressure and heart rate were studied in normo tensive conscious rabbits after i.v. administration. In addition, we investigated relationships between plasma drug concentrations and (3-adrenoceptor blocking activity as estimated by the inhibition of isoproterenol-induced tachycardia and vasodilator activity as assessed by the inhibition of pressor response to angiotensin I I (ANG II). Prizidilol (4 mg/kg) produced a significant and sustained fall in blood pressure and a slight increase in heart rate, while hydralazine (2 mg/kg) caused the same degree of hypotension and a marked tachycardia. Nipradilol (1 mg/kg) caused a significant reduction of resting heart rate, but had no significant effect on blood pressure.
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Propranolol (1 mg/kg) did not affect resting blood pressure and heart rate. Hypertensive response to ANG II was significantly attenuated only by hydralazine.
Isoproterenol -induced tachycardia was significantly suppressed by prizidilol, nipradilol and propranolol.
Good correlations were observed between ;3-adrenoceptor blocking activity and plasma drug concentrations. These data suggest that prizidilol has an advantage over hydralazine to induce less tachycardia, but still may cause a certain degree of increase in heart rate. Nipradilol has a more potent l3-adrenoceptor blocking action than propranolol, while its vasodilator action is not obvious, at least in rabbits.
Plasma concentrations of prizidilol and nipradilol are good indicators for , 3- (8) . The arterial cannula was connected to a pressure transducer (CP-01, Century Technology), and the blood pressure was recorded by a carrier-amplifier system (RP-5 and RTG-408, Nihon Kohden). Heart rate was measured from the lead I ECG using a cardiotachometer system (RB-J5, RB-5, RT-5 and KJR-4008, Nihon Kohden). Four mg/kg prizidilol, 1 mg/kg nipradilol, 2 mg/kg hydralazine, 1 mg/kg propranolol, or 0.1 ml/kg saline was administered through the venous catheter. Blood samples were obtained from the arterial catheter into plastic tubes at the various designated times for analysis of drug concentration. The plasma was separated by centrifugation at 3,000 r.p.m. for 10 min at 4°C and stored at -20°C until assayed .
Vasodilator activity: Percent inhibition of pressor response to angiotensin II (100 ng/ kg) after the administration of the test drugs was used as a parameter for vasodilator activity, because hydralazine and other direct vasodilator drugs are reported to reduce the responses of arterial smooth muscle to various agonistic stimuli such as norepine phrine, epinephrine and angiotensin (9) .
19-Adrenoceptor blocking activity: dl Isoproterenol (0.2 fig/kg) was injected intra venously through the cannula before and at various times after the administration of test drugs. Percent inhibition of tachycardiac response to isoproterenol as compared to its value prior to the test drug administration was used to assess the 8-adrenoceptor blocking activity.
Determination of plasma drug concen trations: Plasma concentration of prizidilol was measured by H PLC as reported by Larsson et al. (10) . Nipradilol in plasma was determined as the heptafluoro-n-butyryl derivative by the selected ion monitoring method in gas chromatography-mass spec trometry (Yoshimura et al., in preparation). Hydralazine was determined after the method of Jack et al. (11) by gas chromatography with an electron capture detector. Pro pranolol was measured by radioimmunoassay (12) .
Drugs and dosage: Prizidilol and nipradilol were kindly supplied by Smith, Kline & French and by Kowa, respectively. For the drugs with a-adrenoceptor blocking action, the doses which produce almost complete inhibition of isopreterenol-induced tachycardia at 30 min after the administration were chosen: prizidilol (4 mg/kg), nipradilol (1 mg/kg), and propranolol (1 mg/kg). The dose of hydralazine (2 mg/kg) which causes almost the same degree of hypotension as prizidilol was used in the study.
Data analysis: Significance of difference among the means was ascertained using Scheffe's S test. Means and standard errors are presented in the text, table and figures.
The plasma drug concentration-time data were fitted to a two-compartment open kinetic model using the computer program TOPFIT (13) . Kinetic parameters were calculated by standard procedures.
Linear least regression was used to examine the relationships between phar macological activities and plasma drug con centrations during the steady-state decline.
Results
Effects on resting blood pressure and heart rate: Before the treatment with drugs, blood pressure and heart rate under the experimental conditions were 92.5±1.4 mmHg and 200±5 beats/min, respectively. The time courses of the changes in resting blood pressure and heart rate after the administration of drugs are shown in Figs. 1 and 2. Prizidilol (4 mg/kg) produced a prompt and sustained fall in blood pressure which was statistically significant at 0.5, 1, and 2 hr compared to the saline treated control (P<0.01 or 0.05), and it caused a slight but obvious increase in resting heart rate. The administration of nipradilol (1 mg/ kg) resulted in an insignificant reduction of blood pressure which was maximum at 30 min and disappeared by 1 hr. Resting heart rate was significantly reduced by nipradilol at 1, 2 and 3 hr (P<0.05). Hydralazine (2 mg/kg) caused a prompt and sustained reduction in resting blood pressure when compared to the control (P<0.05 at 0.5, 1 and 2 hr), and it caused a marked reflex tachycardia.
Propranolol (1 mg/kg) did not produce any significant changes in both resting blood pressure and heart rate.
Effects on pressor response to angiotensin II: Angiotensin II (100 ng/kg, i.v.) increased blood pressure by 27.3±1.9 mmHg from the pretreatment level.
The time courses of the change in pressor response to angiotensin II after the adminis tration of drugs are shown in Fig. 3 . A slight reduction of the response was observed after the administration of prizidilol. Hydralazine produced a significant decrease in the pressor effect of angiotensin II at 0.5 and 1 hr after the administration (P<0.01). Nipradilol did not produce any significant change in the response, while propranolol caused a slight augmentation. Effects on tachycardiac response to iso proterenol: The dose of 0.2 /,,g/kg isopro terenol, i.v., increased heart rate by 114±5 beats/min.
The time courses of the change in isopro terenol-induced tachycardia after the admin istration of drugs are shown in Fig. 4 . Prizidilol, nipradilol and propranolol caused significant inhibition of tachycardiac response to isoproterenol throughout the experimental period of 4 hr (P<0.01). Hydralazine caused an apparent inhibition of the response because hydralazine itself produced a significant reflex tachycardia, and isopro terenol could hardly induce any further increase in heart rate. Relationship between plasma drug con centrations and 9-adrenoceptor blocking activity: Plasma concentrations of prizidilol, nipradilol and propranolol correlated well with the percent inhibition of isoproterenol induced tachycardia (Fig. 6) . The cor relation of propranolol was stronger than those of prizidilol and nipradilol. The apparent inhibition caused by hydralazine weakly correlated with the plasma concentration. 
Discussion
In the present study in normotensive rabbits, prizidilol (4 mg/kg, i.v.) caused a rapid and sustained fall in resting blood pressure and an insignificant but obvious tachycardia. The decreases in blood pressure and heart rate after the dose of prizidilol have been observed in spontaneously hypertensive (SH R) rats and in normotensive cats, while a reflex increase in heart rate associated with a fall in blood pressure has been found in renal hypertensive dogs (2). In both nor motensive and hypertensive humans, a fall in blood pressure has been observed after i.v. infusion or oral administration of prizidilol, while variable effects have been reported on the heart rate (10, 14-17). These data suggest that prizidilol consistently produces a decrease in arterial pressure, but that effects on heart rate may vary depending on the species and the experimental conditions. Thus, the observed increase in heart rate after prizidilol is likely mediated by the partial agonist action (2, 18) , rather than by the insufficient supression of reflex tachycardia. Although hydralazine caused a significant suppression of the pressor response to angiotensin II, prizidilol did not attenuate the response. This is consistent with the results observed in anesthetized cats (2). Kou and Suzuki (6) and Uchida et al. (7) have demonstrated that nipradilol has combined 8-adrenoceptor blocking and nitro glycerin-like direct vasodilator or a-adre noceptor blocking actions at relatively high concentrations in isolated canine blood vessels. Nipradilol is reported to undergo biotransformation into the desnitro derivative, which has about one-tenth the 8-adre noceptor blocking action of the parent drug, but no longer has vasodilator activity (7) . The nitro moiety is therefore essential for nipradilol to exert vasodilator action. In the present study, nipradilol
(1 mg/kg, i.v.) produced a significant reduction in heart rate, but not in blood pressure. However, Uchida et al. (7) reported a significant and sustained fall in blood pressure and a reduction of heart rate in SHR rats after oral administration of nipradilol (3 and 5 mg/kg). One of the reasons of this discrepancy in the effect on blood pressure could be ascribed to the difference in the rate of biotransfor mation to the desnitro derivative between rabbits and SHR rats. Although data are not shown here, we observed rapid formation of the desnitro derivative in rabbits. An alterna tive possibility is that nipradilol might reduce blood pressure more effectively in hyper tensive animals than in normotensives. 
